Metastatic Pancreatic Neuroendocrine Tumors Have Decreased Somatostatin Expression and Increased Akt Signaling

被引：0
|
作者：
Tran, C. [1 ]
Scott, A. [1 ]
Li, G. [1 ]
Sherman, S. [1 ]
Ear, P. H. [1 ]
Howe, J. [1 ]
机构：
[1] Univ Iowa, Dept Surg, Iowa City, IA 52242 USA
来源：
PANCREAS | 2021年 / 50卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
B-1
引用
收藏
页码：441 / 441
页数：1
相关论文
共 50 条
  • [41] Loss of PTEN Expression in Neuroendocrine Pancreatic Tumors
    Krausch, M.
    Raffel, A.
    Anlauf, M.
    Schott, M.
    Willenberg, H.
    Lehwald, N.
    Hafner, D.
    Cupisti, K.
    Eisenberger, C. F.
    Knoefel, W. T.
    HORMONE AND METABOLIC RESEARCH, 2011, 43 (12) : 865 - 871
  • [42] Hedgehog signaling in the pancreatic neuroendocrine system and malignant tumors
    Beate, Alinger
    Ursula, Mayrhauser
    Berta, Lechner
    Otto, Dietze
    Cornelia, Hauser-Kronberger
    VIRCHOWS ARCHIV, 2007, 451 (02) : 144 - 144
  • [43] Pancreatic Neuroendocrine Tumors: Signaling Pathways and Epigenetic Regulation
    Saleh, Zena
    Moccia, Matthew C.
    Ladd, Zachary
    Joneja, Upasana
    Li, Yahui
    Spitz, Francis
    Hong, Young Ki
    Gao, Tao
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (02)
  • [44] Loss of PTEN and Expression of GLUT1 Predict the Metastatic Progression of Pancreatic Neuroendocrine Tumors
    Neyaz, Azfar
    Westendorp, Jasmijn
    Wald, Abigail
    Nikiforova, Marina
    Hong, Seung-Mo
    Heaphy, Christopher
    Brosens, Lodewijk
    Singhi, Aatur
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1225 - 1225
  • [45] Loss of PTEN and Expression of GLUT1 Predict the Metastatic Progression of Pancreatic Neuroendocrine Tumors
    Neyaz, Azfar
    Westendorp, Jasmijn
    Wald, Abigail
    Nikiforova, Marina
    Hong, Seung-Mo
    Heaphy, Christopher
    Brosens, Lodewijk
    Singhi, Aatur
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1225 - 1225
  • [46] Expression and Epigenetic Regulation of E-cadherin in Metastatic Gastrointestinal and Pancreatic Neuroendocrine Tumors and Carcinomas
    Lamzabi, Ihab
    Buckingham, Lela
    Jain, Richa
    Barbanera, William
    Singh, Rohit
    Jakate, Shriram
    Gattuso, Paolo
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2013, 140 : 105 - 105
  • [47] Different Characteristics in Hormonal Expression Between Primary Pancreatic Neuroendocrine Tumors (PNETs) and Metastatic Sites
    Kimura, Hideyo
    Ohtsuka, Takao
    Fujimoto, Takaaki
    Date, Kenjiro
    Matsunaga, Taketo
    Watanabe, Yusuke
    Tamura, Koji
    Abe, Atsushi
    Mizuuchi, Yusuke
    Miyasaka, Yoshihiro
    Yamada, Daisuke
    Igarashi, Hisato
    Ito, Tetsuhide
    Takahata, Shunichi
    Oda, Yoshinao
    Mizumoto, Kazuhiro
    Tanaka, Masao
    GASTROENTEROLOGY, 2015, 148 (04) : S1171 - S1171
  • [48] Dual Inhibition of AKT and mTOR Signaling Pathways Decreases Human Pancreatic Neuroendocrine Tumor (PNET) Metastatic Progression
    Djukom, C.
    Porro, L.
    Mrzek, A.
    Hellmich, M.
    Chao, C.
    PANCREAS, 2012, 41 (08) : 1356 - 1356
  • [49] Is There a Role for Liver Transplantation in Metastatic Pancreatic Neuroendocrine Tumors (PNET)?
    Gulati, Anthony Paul
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2012, 13 (03): : 320 - 321
  • [50] A mouse model for highly metastatic, nonfunctioning pancreatic neuroendocrine tumors
    Contractor, Tanupriya
    Kobayashi, Shinta
    Clausen, Richard
    da Silva, Edaise
    Tang, Laura
    Chan, Chang
    Harris, Chris R.
    CANCER RESEARCH, 2016, 76
12345